This political and social info is just a part of my DD on
This political and social info is just a part of my DD on LL which I'd usually leave out with other biotech stocks. LL is different since it may present a serious challenge to the very existing system of power/money way beyond Big Pharma. If our hopes for LL power over Cancer and other mass lethal diseases come true this challenge may rise to the status of existential. Covid is just a tip of the iceberg. It is the possible prophylactic effect of LL that can turn the social-political situation upside down. Let's take for illustration just a relatively marginal case of Philippines.
In his last public appearance Dr. Richard Nicholas pointed out that none of his Filipino patients he'd treated with LL developed LH Covid symptoms. He emphasized the importance of this fact by repeating this statement in native Tagalog. Now I am trying to imagine the effect of this on two Filipino groups: the VIP class and the people. Had I belonged to the former I would make sure to receive LL at the earliest signs of COVId infection and this is why I'd be in support of the existing LL supply system to Philippines giving my VIP class access to the molecule, only perhaps making it somewhat less time consuming. But if I am one of those 20% with USD 175 a month or even a member of the middle-class with the family income between USD450-1500 I wouldn't be happy at all with the way the system works. Still I may find some comfort in the relative accessibility of the Chinese vaccine or in the hope of having a mild case and even the idea that all pandemics end sooner or later.
But what if the 99% of Filipino society learns that LL is more effective than any other drugs against cancer and a host of other lethal mass deceases, that it empowers our immune system to prevent the development of these diseases and that LL is absolutely safe? Unlike pandemics, cancer is going nowhere. It's growing undetected right now in the bodies of millions around the world and millions are dying of it right now. And the world population is getting greyer and more susceptible to deadly ills with each passing day. And Professor Sison's Communist Party tell the Filipino poor (the majority of the country) that only by liberating their country of Yankee imperialism--which incidentally includes the FDA and BPharma--a health system for the people is possible... This is what I call LL's systemic challenge.
8
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...
Continue Reading
Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....
Continue Reading
Black Friday: A Pool Owner's Break It’s not every day you stumble upon savings like these—Aiper is throwing some meaty discounts this Black Friday, saving pool owners up to a juicy $550 off robotic cleaners. Imagine that! For anyone with a pool to maintain, these deals might just be the ticket to less grunt work and more time lounging with a cold drink in hand....
Continue Reading
Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...
Continue Reading
SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...
Continue Reading
Blokees Partners with Iconic Virtual Star Hatsune Miku There's a new player cozying up in the world of virtual icons, and it's none other than Blokees. If you haven't heard, Blokees just dipped its toes into the buzzing waters of the Hatsune Miku fandom by becoming an official strategic partner at the 'MIKU WITH YOU 2026' concert in Shanghai. You could call this a step up...
Continue Reading
Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...
Continue Reading
Ericsson's Latest Move into Drone Detection Brace yourself, folks! Ericsson is taking things to a whole new altitude, literally. They're bringing drone detection capabilities right to our mobile networks. It's like they're transforming our standard network towers into stealthy drone spotters. Think about a mobile network that not only keeps your calls from dropping but...
Continue Reading
Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...
Continue Reading
Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...
Continue Reading
Top 5 Most Recently Viewed Articles
TC BioPharm's Transition to OTC Markets TC BioPharm (Holdings) PLC, known for its innovative work in gamma-delta T cell therapies, has made a significant announcement regarding its market standing. The company, which has been publicly traded on Nasdaq, will be making a shift to the OTC Markets due to recent developments concerning its listing status. The transition...
Continue Reading
Overview of President Trump's First Days in Office Washington, DC, saw an energetic start as President Trump commenced his term. In this review, we highlight the notable actions taken during his initial 100 hours, underscoring his commitment to making significant changes. Executive Orders and Their Implications In the early hours of his presidency, President Trump...
Continue Reading
Interparfums, Inc. Expands Portfolio with Off-White Fragrance Interparfums, Inc. (NASDAQ: IPAR) is making waves in the fragrance industry with its recent acquisition of the Off-White brand names and trademarks for fragrance and cosmetic products. This strategic move comes through its majority-owned subsidiary, Interparfums SA, which is positioned to start leveraging these...
Continue Reading
Gain Therapeutics, Inc. (Nasdaq: GANX) hit the scene as a fresh player in the biotech world, but traders were skeptical. Back in 2024, they got buzzed for their potential to shake up treatments with their allosteric small molecule therapies, focusing on Parkinson's disease among other targets. And you know how it goes in this game; expectations can skyrocket or tank real...
Continue Reading
Investors Gear Up for Legal Battle There's nothing quite like the sound of a gavel about to drop when a company gets tangled up in a securities fraud lawsuit. This time, Aardvark Therapeutics, Inc. is in the hot seat. Shareholders are ruffling their feathers, and they're ready to take the company to court over claims of misleading information. You know the drill: someone...
Continue Reading